IGAU
IGAU is a São Paulo-headquartered physician-led urology network delivering advanced robotic, focal-therapy, and minimally invasive treatments for prostate, kidney, bladder, and testicular cancers across premium Brazilian hospitals and a multi-country specialist referral network.
- Company typePrivate
- Founded2020
- HeadquartersSão Paulo, Brazil
- Headcount11–50
- GTM typeB2C
- OfferingServices
What IGAU does
IGAU (International Group of Advanced Urology) is a São Paulo, Brazil-headquartered physician-led urology network founded by Prof. Dr. Arie Carneiro and organized as a multi-country association of specialists. Its core function is the delivery of advanced minimally invasive and robotic urological care — predominantly prostate cancer, kidney cancer, bladder cancer, testicular cancer, and benign prostatic hyperplasia — to patients in Brazil and Latin America, with international referral pathways to specialists in the USA, France, Italy, Spain, Argentina, and Chile.
The service portfolio is built around three hardware pillars: (1) robotic surgery using the Intuitive Da Vinci Xi platform and the Medtronic HUGO RAS system (Hospital Albert Einstein was first in Brazil to deploy HUGO RAS); (2) focal therapies using EDAP-TMS Focal One HIFU and Nanoknife irreversible electroporation for prostate and kidney cancer; and (3) minimally invasive BPH treatments including HOLEP (holmium laser enucleation) and REZUM (steam vapor). Procedures are performed across a network of premium São Paulo hospitals — Hospital Albert Einstein, HCOR, Hospital Oswaldo Cruz, Hospital São Luiz, Hospital Sírio-Libanês, and Hospital 9 de Julho — leveraging Dr. Carneiro's credentialing as a robotic-surgery and HIFU proctor at Harvard and other US centers.
Revenue is generated on a professional-services basis through outpatient consultations, surgical procedures (robotic, focal, and laser), and surgeon training/fellowship programs, with fees collected under Brazilian private health insurance and private-pay arrangements; no public pricing or revenue figures are disclosed. The organization operates without external capital, holding no identified funding rounds, M&A, or institutional investors, and is governed by a scientific committee of internationally affiliated urologists. Marketing is concentrated on owned digital channels (website, YouTube, Instagram) and earned media, with the founder's KOL status and 40+ Brazil-wide surgical-robot installed base cited as market context.
IGAU firmographics
Firmographics- Name
- IGAU
- Legal name
- International Group of Advanced Urology
- Website
- https://ariecarneiro.com.br
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- IGAU is a São Paulo-headquartered physician-led urology network delivering advanced robotic, focal-therapy, and minimally invasive treatments for prostate, kidney, bladder, and testicular cancers across premium Brazilian hospitals and a multi-country specialist referral network.
- Ownership category
- akta.pro rank
IGAU industry classification
Industry- Product category
- Urology Healthcare Services
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Urologic Oncology (HLAKAOAB)
- akta.pro secondary industries
- Endourology & Minimally Invasive Urologic Surgery (HLAKAOAF), Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)
Keywords
Where IGAU is headquartered
LocationHeadquarters
- HQ city
- São Paulo
- HQ country
- Brazil
- HQ region
- Latin America
Offices3 records
Markets served
IGAU business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Medical Consultation Services: Outpatient medical consultations at Hospital Albert Einstein and partner facilities in São Paulo
- Surgical Procedures: Revenue from robotic surgeries, HIFU treatments, and other minimally invasive urological procedures
- Medical Training and Education: Training programs for surgeons in robotic surgery and HIFU techniques at partner institutions
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
IGAU product offering
Product offeringCore offering
IGAU operates a global network of specialist urologists delivering advanced minimally invasive and robotic surgical treatments for urological diseases — primarily prostate cancer, kidney cancer, bladder cancer, testicular cancer, and benign prostatic hyperplasia — using Da Vinci Xi and HUGO RAS robotic platforms, HIFU focal therapy (Focal One), HOLEP, REZUM, and Nanoknife. Patient care is delivered at partner hospitals in São Paulo, with cross-border referrals to affiliated institutions in the USA, France, Italy, Spain, Argentina, and Chile. The network also runs postgraduate training and proctoring programs in robotic surgery and HIFU for surgeons.
Product overview
IGAU (International Group of Advanced Urology) is a global network of renowned urologists offering advanced urological treatments through a combination of robotic surgery platforms (Da Vinci Xi and HUGO RAS), focal therapies (HIFU, Nanoknife), and minimally invasive procedures (REZUM, HOLEP). The network connects specialists from leading institutions in Brazil, USA, France, Italy, Spain, Chile, and Argentina, providing patients with access to cutting-edge urological care including prostate cancer treatment, kidney surgery, and bladder procedures.
Differentiator
Problem solved
Functional benefit
Products and services
- Robotic Surgery (Da Vinci Xi)
- HUGO RAS Robotic Surgery
- HIFU (High Intensity Focused Ultrasound) Focal Therapy
- HOLEP (Holmium Laser Enucleation of the Prostate)
- REZUM Steam Vapor Therapy
- Nanoknife (Irreversible Electroporation)
- Focal One HIFU Device Treatment
Quantifiable outcome
- 2,000+ robotic surgeries performed with excellent outcomes
- +2 more outcomes
Companies that use IGAU
Customer profileNamed customers5 records
Segments2 records
Ideal customer profiles3 records
IGAU technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
IGAU partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and key.
- Hospital Albert EinsteincorePrimary partner institution in Brazil. Dr. Arie Carneiro serves as coordinator of the robotic surgery postgraduate program and proctor for robotic surgery and HIFU focal therapy at this institution.
- Harvard Medical School (Beth Israel Deaconess Medical Center)coreDr. Arie Carneiro conducted doctoral research (sandwich program) and training. Serves as HIFU proctor/instructor, training Harvard surgeons in focal therapy techniques.
- Université Paris Descartes / Institut Mutualiste MontsouriscoreDr. Carneiro completed clinical fellowship in minimally invasive and robotic surgery. Scientific committee member Rafael Sanchez-Salas based at Institut Montsouris.
- University of MiamikeyScientific committee member Bruno Nahar based at University of Miami. Dr. Carneiro conducted training programs for urologists.
- Washington UniversitykeyScientific committee member Arjun Sivaraman based at Washington University School of Medicine.
- European Institute of Oncology (Italy)keyScientific committee member Ettore Di Trapani based at this Milan institution.
- Hospital Urologico Puigvert (Spain)keyScientific committee member Javier Sanchez Macias affiliated with this Spanish urology center.
- Intuitive SurgicalcoreProvider of Da Vinci Xi robotic surgical system. IGAU team trained and certified on Da Vinci platform.
- MedtroniccoreProvider of HUGO RAS robotic platform. Hospital Albert Einstein was first in Brazil to acquire this platform, with IGAU team chosen for initial training.
- EDAP-TMS (Focal One)coreProvider of Focal One HIFU device used for prostate cancer focal therapy.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
IGAU competitors and assessment
Company assessmentBroad incumbents
- Cleveland Clinic - Glickman Urological & Kidney Institute: One of the largest US academic urology programs, with deep robotic surgery, focal therapy, and urologic oncology capabilities. Broad incumbent: comparable service offering but at much greater scale and as part of a multi-specialty system; competes for international uro-oncology referrals.
- European Institute of Oncology (IEO): Milan-based comprehensive cancer center with a high-volume urologic oncology program in robotic and laparoscopic surgery. Broad incumbent: IGAU scientific committee member Ettore Di Trapani is affiliated with IEO, and both institutions compete for uro-oncology referrals in their respective geographies.
- USC Keck School of Medicine - Institute of Urology: US academic urology program known for pioneering work in robotic prostatectomy and focal therapy, including HIFU. Broad incumbent: directly overlapping clinical technology stack (Da Vinci, HIFU/focal therapy) and training mission; competes for complex international uro-oncology cases.
- Hospital Israelita Albert Einstein: São Paulo-based premium private hospital ranked among Latin America's top institutions, with a robust urology service anchored by IGAU's founder (Coordinator of robotic surgery postgraduate program). Broad incumbent: the host institution for most of IGAU's procedures, but a multi-specialty system rather than a specialty urology network.
- Memorial Sloan Kettering Cancer Center - Urology Service: US NCI-designated comprehensive cancer center with a leading urologic oncology service covering prostate, kidney, bladder, and testicular cancers using robotic and focal therapy. Broad incumbent: comparable subspecialty focus in urologic oncology, though housed within a much larger oncology enterprise; affiliations (Arjun Sivaraman trained at MSKCC, Rafael Sanchez-Salas did a fellowship there) connect it into the same KOL network as IGAU.
- Karolinska University Hospital - Urology: Swedish academic tertiary hospital with a high-volume robotic urology and urologic oncology program, including prostate cancer focal therapy. Broad incumbent: comparable specialty scope and academic posture, though operating inside a publicly funded Nordic system rather than a private-pay model.
Regional players
- A.C. Camargo Cancer Center: Major São Paulo-based private oncology hospital covering urologic oncology among other cancer types, with robotic and minimally invasive surgery capability. Regional player: directly comparable Brazilian urologic oncology footprint and patient base, competing for the same private-pay and insured oncology population.
Direct peers
- Hospital Urológico Puigvert: Barcelona specialty urology hospital entirely focused on urology and nephrology, treating complex oncology, BPH, and stones cases with minimally invasive and robotic techniques. Direct peer: IGAU scientific committee member Javier Sanchez Macias is affiliated with Puigvert, and both institutions operate as referral hubs for their respective regions.
- Institut Mutualiste Montsouris: Paris-based specialty center globally recognized as a pioneer in minimally invasive and robotic urology, including HIFU focal therapy. Direct peer: IGAU's scientific committee is represented there (Rafael Sanchez-Salas) and Dr. Carneiro did his clinical fellowship in robotic surgery at Montsouris, mirroring IGAU's technique stack and patient mix.
- OLV Hospital Aalst: Belgian private hospital internationally known for pioneering robotic radical prostatectomy (Aalst technique) and high-volume urologic oncology surgery. Direct peer: comparable specialty focus on robotic urologic surgery, HIFU/adrenal/renal focal approaches, and academic-led training programs.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
IGAU social profiles
Digital presenceIGAU financial estimates
Financial estimateRevenue estimate
Valuation estimate
IGAU leadership team
Management profileNumber of profiles
Profiles6 records
IGAU funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IGAU M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IGAU
What does IGAU do?
IGAU operates a global network of specialist urologists delivering advanced minimally invasive and robotic surgical treatments for urological diseases — primarily prostate cancer, kidney cancer, bladder cancer, testicular cancer, and benign prostatic hyperplasia — using Da Vinci Xi and HUGO RAS robotic platforms, HIFU focal therapy (Focal One), HOLEP, REZUM, and Nanoknife. Patient care is delivered at partner hospitals in São Paulo, with cross-border referrals to affiliated institutions in the USA, France, Italy, Spain, Argentina, and Chile. The network also runs postgraduate training and proctoring programs in robotic surgery and HIFU for surgeons.
Is IGAU a public or private company?
IGAU is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was IGAU founded?
IGAU was founded in 2020. It employs 11 to 50 people.
Where is IGAU based?
IGAU is headquartered in São Paulo, Brazil, in the Latin America region.
How does IGAU make money?
Three revenue lines are on record. Medical Consultation Services are the primary driver. The others are surgical Procedures and medical Training and Education.
Who are IGAU's main competitors?
Broad incumbents on record are Cleveland Clinic - Glickman Urological & Kidney Institute, European Institute of Oncology (IEO), USC Keck School of Medicine - Institute of Urology, Hospital Israelita Albert Einstein, Memorial Sloan Kettering Cancer Center - Urology Service and Karolinska University Hospital - Urology. A.C. Camargo Cancer Center is listed as a regional player. Direct peers are Hospital Urológico Puigvert, Institut Mutualiste Montsouris and OLV Hospital Aalst.
Does IGAU have an API?
No public API is recorded for IGAU.
What industry is IGAU in?
IGAU's product category is Urology Healthcare Services. Its primary akta.pro industry code is HLAKAOAB, Urologic Oncology, with a secondary code of HLAKAOAF, Endourology & Minimally Invasive Urologic Surgery. Its SIC code is 8011.